Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KM3D Multicenter Cancer Consortium Study: Validation of In Vitro 3D Cell Culture Models for Tumor Drug Sensitivity After Tissue Removal

NCT05338073 is registered in ClinicalTrials.gov with Known Medicine, Inc. as lead sponsor.

NCT NCT05338073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05338073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KM3D Multicenter Cancer Consortium Study: Validation of In Vitro 3D Cell Culture Models for Tumor Drug Sensitivity After Tissue Removal
Lead sponsor
Known Medicine, Inc.
Phase
Observational
Overall status
Unknown status
Start date
January 12, 2021
Completion date
January 31, 2026
Enrollment
2,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, effects of chemotherapy, predictive cancer model